Susquehanna Maintains Positive on MaxLinear, Lowers Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
Susquehanna analyst Christopher Rolland maintains a Positive rating on MaxLinear (NASDAQ:MXL) but lowers the price target from $30 to $26.

July 25, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Susquehanna analyst Christopher Rolland maintains a Positive rating on MaxLinear but lowers the price target from $30 to $26.
The maintained Positive rating suggests continued confidence in MaxLinear's performance, but the lowered price target indicates some caution about its short-term prospects. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100